Natera (NASDAQ:NTRA) Now Covered by Royal Bank of Canada
Equities researchers at Royal Bank of Canada initiated coverage on shares of Natera (NASDAQ:NTRA – Get Free Report) in a research report issued on Thursday, MarketBeat.com reports. The firm set an “outperform” rating and a $251.00 price target on the medical research company’s stock. Royal Bank of Canada’s price target indicates a potential upside of […]
